Role of urine osmolality as a predictor of the effectiveness of combined imipramine and desmopressin in the treatment of monosymptomatic nocturnal enuresis
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: We examined the usefulness of urine osmolality, as a predictive factor in the treatment of monosymptomatic nocturnal enuresis (NE) with combination therapy of imipramine and desmopressin. Methods: From May 2014 to April 2015, 59 monosymptomatic NE patients participated in this study. Early morning urine osmolality was measured at 1 week and 1 day before combination therapy of imipramine and desmopressin, and at 1 week and 2 weeks after therapy. The response to combination therapy was evaluated at 3 months after treatment. The mean period of combination therapy was 6.4± 4.2 weeks. Therapeutic response was classified as complete (0-1 wet night/week), partial (over 50% reduction of night) and non-responders (less than 50% reduction of night). Results: The cumulative rate of the complete and partial responders was 76.3%. Among the 3 groups, the statistically lowest value of pre-treatment urine osmolality was observed in the complete responder group (p<0.001). Urine osmolality increased in all groups after treatment, however, statistically the greatest difference between pre and post-treatment urine osmolality was observed in the complete responder group (p=0.024). No serious side effects were observed. Conclusion: Early morning urine osmolality and change of urine osmolality between pre and post-treatment have predictive values in the response to combined imipramine and desmopressin for treatment of monosymptomatic NE.
Abstract
Background: We examined the usefulness of urine osmolality, as a predictive factor in the treatment of monosymptomatic nocturnal enuresis (NE) with combination therapy of imipramine and desmopressin. Methods: From May 2014 to April 2015, 59 monosymptomatic NE patients participated in this study. Early morning urine osmolality was measured at 1 week and 1 day before combination therapy of imipramine and desmopressin, and at 1 week and 2 weeks after therapy. The response to combination therapy was evaluated at 3 months after treatment. The mean period of combination therapy was 6.4± 4.2 weeks. Therapeutic response was classified as complete (0-1 wet night/week), partial (over 50% reduction of night) and non-responders (less than 50% reduction of night). Results: The cumulative rate of the complete and partial responders was 76.3%. Among the 3 groups, the statistically lowest value of pre-treatment urine osmolality was observed in the complete responder group (p<0.001). Urine osmolality increased in all groups after treatment, however, statistically the greatest difference between pre and post-treatment urine osmolality was observed in the complete responder group (p=0.024). No serious side effects were observed. Conclusion: Early morning urine osmolality and change of urine osmolality between pre and post-treatment have predictive values in the response to combined imipramine and desmopressin for treatment of monosymptomatic NE.
참고문헌 (16)
- Butler RJ, "Establishment of working definitions in nocturnal enuresis", Arch Dis Child, 66, pp.267~271 (1991)
- Husmann DA, "Enuresis", Urology, 48, pp.184~193 (1996)
- Forsythe WI, "Enuresis and spontaneous cure rate. Study of 1129 enuretis", Arch Dis Child, 49, pp.259~263 (1974)
- Foxman B, "Childhood enuresis: prevalence, perceived impact, and prescribed treatments", Pediatrics, 77, pp.482~487 (1986)
- 강정윤, "야뇨증 환아에서 Imipramine과 DDAVP의 치료 효과: 무작위 전향적 연구", Investigative and Clinical Urology, 44(7), pp.665~671 (2003), 대한비뇨기과학회
- 박용훈, "어린이의 일차성 단일증상성 야뇨증에서 imipramine과 desmopressin 복합 약물치료의 효과 및 안전성", Childhood Kidney Diseases, 8(2), pp.129~137 (2004), 대한소아신장학회
- 조현민, "야뇨증 환아에서 방광용적과 요비중 및 다른 인자들로 Desmopressin에 대한 반응을 예측할 수 있는가?", Investigative and Clinical Urology, 43(4), pp.303~307 (2002), 대한비뇨기과학회
- MacLean RE, "Imipramine hydrochloride (Tofranil) and enuresis", Am J Psychiatry, 117, pp.551~ (1960)
- Hunsballe JM, "Single dose imipramine reduces nocturnal urine output in patients with nocturnal enuresis and nocturnal polyuria", J Urol, 158, pp.830~836 (1997)
- Robson WL, "Hyponatremia in patients with nocturnal enuresis treated with DDAVP", Eur J Pediatr, 155, pp.959~962 (1996)
- Jung JY, "Effects of combined drug therapy in the nocturnal enuretic patients", Korean J Urol, 39, pp.70~76 (1998)
- Reinberg Y, "Treatment of refractory monosymptomatic nocturnal enuresis with combination therapy of desmopressin and imipramine", Pediatrics, 98(Suppl), pp.8~ (1996)
- Steffens J, "Vasopressin deficiency in primary nocturnal enuresis. Results of a controlled prospective study", Eur Urol, 24, pp.366~370 (1993)
- Nevéus T, "Enuresis--background and treatment", Scand J Urol Nephrol Suppl, 206, pp.1~44 (2000)
- Läckgren G, "Diurnal plasma vasopressin and urinary output in adolescents with monosymptomatic nocturnal enuresis", Acta Paediatr, 86, pp.385~390 (1997)
- Rushton HG, "The influence of small functional bladder capacity and other predictors on the response to desmopressin in the management of monosymptomatic nocturnal enuresis", J Urol, 156, pp.651~655 (1996)